학술논문
In vitro pharmacological profile of GLPG3667 suggests differentiation from the TYK2 inhibitors deucravacitinib and TAK-279 at their clinical dose regimens
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
18764479